Sure Hervé Hoppenot took a big cut in compensation after a pipeline disaster. But he still outscored the only woman on the list
After a brutal year at the helm, Incyte CEO Hervé Hoppenot took a big cut in annual compensation for 2018 — but he still made more than GSK CEO Emma Walmsley.
Basic subscription required
Unlock this story instantly and join 53,100+ biopharma pros reading Endpoints daily — and it's free.